Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Video Gaming and eSports ETF (ESPO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

VanEck Video Gaming and eSports ETFTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

VanEck Video Gaming and eSports ETF vs State Street SPDR S&P Biotech ETF — how do they compare? VanEck Video Gaming and eSports ETF trades at $91.98, while State Street SPDR S&P Biotech ETF trades at $151.94. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals.

ESPOXBI
Sector
Sector/ThematicBroad Market / Factor
52-Week High
$122.30$164.28
52-Week Low
$85.25$85.16

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Video Gaming and eSports ETF

ESPO trades at $91.98, up 0.47% today, with technical indicators showing a bullish trend supported by moving averages. The ETF benefits from positive sentiment around AI-driven profit potential in the gaming industry. Recent institutional buying by Assetmark Inc. highlights growing confidence in the digital entertainment sector's growth prospects.

The outlook remains positive given AI's potential to boost gaming industry profits by $22 billion, though risks include sector competition and market volatility. Current technical strength near key support levels suggests potential for continued upward momentum if broader market conditions remain favorable.

State Street SPDR S&P Biotech ETF

XBI (SPDR S&P Biotech ETF) trades at $152.07, down 2.23% today, but maintains a bullish technical outlook with strong momentum indicators. The ETF has gained significant attention with a 17% monthly surge, driven by biotech sector strength and increased M&A activity. Analyst coverage shows a cautious stance with 100% hold rating, reflecting balanced risk-reward assessment amid sector volatility.

The biotech sector shows strong momentum with AI drug discovery advances and record M&A activity ($106 billion in 2026). While XBI offers high-beta exposure to small/mid-cap biotech growth, investors face elevated volatility and regulatory uncertainties. The equal-weight portfolio structure provides diversified exposure to sector innovation but requires tolerance for price swings.

Returns comparison

Trailing returns across standard periods

About VanEck Video Gaming and eSports ETF

ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.

Read more on ESPO

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI